A long-term open-label study to evaluate the safety and tolerability of brexpiprazole as maintenance treatment in adults with schizophrenia

Authors
Category Primary study
ConferenceNeuropsychopharmacology
Year 2016
This article has no abstract
Epistemonikos ID: 676e08b25f32e17de9745ed6a8b1ed0847bd018f
First added on: Apr 29, 2026